Kansas City Research Institute, LLC

Kansas City, Missouri 64131

0 studies enrolling now · 6 studies all time

What they study most

Hepatic Impairment, Hepatitis C Virus Infection, Hepatitis C, Chronic, Non-alcoholic Steatohepatitis, Ulcerative Colitis

Studies at this site

• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis — Stopped early
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function — Stopped early
• Gilead Sustained Virologic Response (SVR) Registry — Completed